Sugar & Serenity: End-of-Life Diabetes Care-Discussion and Q&A

Video Transcription

Video Summary

Dr. Riddle addressed questions on diabetes management in hospice care, emphasizing recommendations apply across all care levels, especially routine home care, focusing on comfort rather than tight glucose control. Diabetes' relation to primary diagnosis varies case-by-case; it’s often unrelated in non-pancreatic malignancies unless treatments affect glucose. He supports deprescribing anticoagulants like Eliquis to aspirin in atrial fibrillation for safety, balancing risks. Continuous glucose monitors aren't recommended in end-of-life care due to potential distress. Target glucose ranges of 100-275 mg/dL prioritize comfort over long-term control. Easing dietary restrictions and treatments improves quality of life, shifting focus from strict management to comfort and presence.

Keywords

diabetes management

hospice care

comfort-focused glucose control

deprescribing anticoagulants

quality of life in end-of-life care